Study to Evaluate the Safety and Pharmacokinetics of CKD-379
NCT05952219
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Type II Diabetes Mellitus
Interventions
DRUG:
CKD-379
DRUG:
D759+D745+D029+D150
Sponsor
Chong Kun Dang Pharmaceutical